A Trial Investigating the Cardiovascular Safety of Oral Semaglutide in Subjects With Type 2 Diabetes
A Trial Investigating the Cardiovascular Safety of Oral Semaglutide in Subjects With Type 2 Diabetes
This trial is conducted globally. The aim of the trial is to investigate the cardiovascular safety of oral semaglutide in subjects with type 2 diabetes.
Inclusion Criteria:
Exclusion Criteria:
CABA, C1120AAC, Argentina
CABA, C1428ART, Argentina
CABA, C1440AAD, Argentina
Oldenburg I. Holst, 23758, Germany
Saint Ingbert-Oberwürzbach, 66386, Germany
Hyderabad, Andhra Pradesh 500034, India
Hyderbad, Andhra Pradesh 500 012, India
Goa, Maharashtra 403 202, India
New Dehli, New Delhi 110029, India
Ipoh, Perak, 30990, Malaysia
Middleburg, Mpumalanga 1055, South Africa
Fuenlabrada - Madrid, 28942, Spain
Norfolk, NR4 7UQ, United Kingdom